Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐...
Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
About this item
Full title
Author / Creator
Jaffuel, Dany , Nogue, Erika , Berdague, Philippe , Galinier, Michel , Fournier, Pauline , Dupuis, Marion , Georger, Frédéric , Cadars, Marie‐Pierre , Ricci, Jean‐Etienne , Plouvier, Nathalie , Picard, François , Puel, Vincent , Mallet, Jean‐Pierre , Suehs, Carey M. , Molinari, Nicolas , Bourdin, Arnaud and Roubille, François
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims
Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation based on six studies encompassing a total of 67 patients only. Whether sacubitril–valsartan (SV), a cornerstone of HFrEF medical treatment, impacts SA is unknown and requ...
Alternative Titles
Full title
Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dca2b3897fed41f8b671201edae89711
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dca2b3897fed41f8b671201edae89711
Other Identifiers
ISSN
2055-5822
E-ISSN
2055-5822
DOI
10.1002/ehf2.13455
